Why MDC Remains Essential for Moisture-Sensitive Tablet Coating Applications
Tablet coating plays a vital role in pharmaceutical manufacturing. It improves product stability, enhances tablet appearance, supports controlled drug release, and protects sensitive active pharmaceutical ingredients from external environmental conditions. While aqueous coating systems are widely preferred because of their safety and environmental advantages, they are not always suitable for formulations that react negatively to moisture exposure. In such cases, pharmaceutical coating processes require alternative solvent systems capable of delivering reliable coating performance without compromising formulation stability.
Moisture sensitive drug formulations present unique manufacturing challenges. Exposure to water during coating may trigger degradation of the active ingredient, reduce shelf life, alter tablet hardness, or create coating defects such as cracking and poor adhesion. These risks can affect both therapeutic performance and regulatory compliance. As a result, non aqueous coating technologies remain essential for specific pharmaceutical applications where moisture control is critical throughout processing.
Methylene Dichloride, commonly known as MDC, is widely used in specialised tablet coating systems because of its strong solvency and rapid evaporation characteristics. It effectively dissolves pharmaceutical polymers including ethyl cellulose, cellulose acetate, acrylic polymers, and polyvinyl derivatives used in protective coating formulations. Once applied to the tablet surface, MDC evaporates quickly, leaving behind a smooth and uniform coating layer with minimal moisture exposure to the active ingredient.
The fast evaporation profile of MDC also supports improved process efficiency. Reduced drying times help maintain production continuity and minimise prolonged heat exposure during coating cycles. In addition, the solvent contributes to improved coating consistency by enabling complete polymer dissolution and stable spray performance throughout the coating operation. This supports uniform film formation and predictable product quality across batches.
Despite its effectiveness, MDC requires careful process management because it is classified as a regulated Class 2 solvent. Residual solvent levels must remain within accepted regulatory limits established under international pharmaceutical guidelines. Controlled drying conditions, validated analytical testing methods, and routine batch monitoring are therefore essential. Gas chromatography is commonly used to confirm residual solvent compliance and maintain product safety standards.
Proper ventilation systems, solvent vapour monitoring, and controlled handling procedures are equally important for maintaining operational safety and environmental compliance. In highly specialised pharmaceutical coating applications where aqueous systems fail to deliver adequate stability, MDC continues to provide a dependable and technically effective solution for moisture sensitive formulations.
Source - https://purosolv.com/when-aqueous-fails-the-role-of-mdc-in-moisture-sensitive-tablet-coating/

Comments
Post a Comment